Welcome to LookChem.com Sign In|Join Free
  • or
(R)-2-(4-Methoxyphenyl)-1-methylethanamine, commonly known as para-Methoxyamphetamine (PMA), is a psychoactive drug belonging to the substituted amphetamine class. It possesses both stimulant and hallucinogenic properties, making it a popular recreational substance for its euphoric effects. As a serotonin and norepinephrine reuptake inhibitor, PMA increases the levels of these neurotransmitters in the brain, leading to its psychoactive effects. However, it is also known to cause severe side effects such as increased heart rate, elevated blood pressure, hyperthermia, and vasoconstriction. Due to its potent and unpredictable nature, PMA has been associated with numerous overdose and fatality cases. In the United States, PMA is classified as a Schedule I controlled substance, making it illegal to manufacture, possess, or distribute for any purpose.

58993-79-6

58993-79-6 Suppliers

This product is a nationally controlled contraband or patented product, and the Lookchem platform doesn't provide relevant sales information.

58993-79-6 Usage

Uses

Used in Recreational Drug Use:
(R)-2-(4-Methoxyphenyl)-1-methylethanamine, or PMA, is used as a recreational drug for its euphoric effects. It is sought after for its stimulant and hallucinogenic properties, providing users with a sense of euphoria and heightened energy.
However, it is important to note that the use of PMA for recreational purposes is illegal and highly dangerous due to its potent and unpredictable effects, which can lead to severe health risks, including overdose and fatalities.

Check Digit Verification of cas no

The CAS Registry Mumber 58993-79-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,8,9,9 and 3 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 58993-79:
(7*5)+(6*8)+(5*9)+(4*9)+(3*3)+(2*7)+(1*9)=196
196 % 10 = 6
So 58993-79-6 is a valid CAS Registry Number.
InChI:InChI=1/C10H15NO/c1-8(11)7-9-3-5-10(12-2)6-4-9/h3-6,8H,7,11H2,1-2H3/t8-/m1/s1

58993-79-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name (2R)-1-(4-methoxyphenyl)propan-2-amine

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:58993-79-6 SDS

58993-79-6Synthetic route

(R)-1-(4-methoxyphenyl)-N-((R)-1-phenylethyl)propan-2-amine
140173-30-4

(R)-1-(4-methoxyphenyl)-N-((R)-1-phenylethyl)propan-2-amine

(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

Conditions
ConditionsYield
With palladium 10% on activated carbon; hydrogen In methanol at 40℃; for 24h;99.8%
With palladium 10% on activated carbon; hydrogen In methanol at 45℃; under 15201 Torr; for 8h; Autoclave;94%
With palladium 10% on activated carbon at 50℃; under 37503.8 Torr; for 1h;
4-methoxybenzyl methyl ketone
122-84-9

4-methoxybenzyl methyl ketone

2-Pentanone
107-87-9

2-Pentanone

B

(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

Conditions
ConditionsYield
With Candida boidinii formate dehydrogenase; pyridoxal 5'-phosphate; Aspergillus terreus ω-trans aminase; Lysinibacillus fusiformis leucine dehydrogenase; ammonium formate; nicotinamide adenine dinucleotide In aq. buffer at 30℃; for 24h; pH=8.8; Catalytic behavior; Green chemistry; Enzymatic reaction;A 99.7%
B 99.4%
4-methoxybenzyl methyl ketone
122-84-9

4-methoxybenzyl methyl ketone

(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

Conditions
ConditionsYield
With glucose dehydrogenase; D-Alanine; D-glucose; ω-transaminase ATA-117; pyridoxal 5'-phosphate; nicotinamide adenine dinucleotide; lactate dehydrogenase In dimethyl sulfoxide at 30℃; for 24h; pH=7; aq. phosphate buffer; Enzymatic reaction; optical yield given as %ee; stereoselective reaction;99%
With pyridoxal 5'-phosphate; amine transaminase TA-P2-B01; isopropylamine In aq. phosphate buffer at 30℃; for 24h; pH=7.5; Reagent/catalyst; Enzymatic reaction; enantioselective reaction;86%
With Cb-FDH formate dehydrogenase (variant) from Candida boidinii; Rs-PhAmDH amine dehydrogenase variant from the phenylalanine dehydrogenase from Rhodoccoccus species; NAD; ammonium formate In water at 30℃; for 24h; pH=8.5; Reagent/catalyst; Enzymatic reaction; stereoselective reaction;82%
(4R,5S)-5-(4-methoxyphenyl)-4-methyloxazolidin-2-one
957777-98-9

(4R,5S)-5-(4-methoxyphenyl)-4-methyloxazolidin-2-one

(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal In methanol at 20℃; for 1h; atmospheric pressure;91%
(R)-N-[2-(4'-methoxyphenyl)-1-methylethyl]-2-methoxyacetamide
1351781-80-0

(R)-N-[2-(4'-methoxyphenyl)-1-methylethyl]-2-methoxyacetamide

(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

Conditions
ConditionsYield
With water; potassium hydroxide Reflux; optical yield given as %ee;70%
C14H23NO2S

C14H23NO2S

(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

Conditions
ConditionsYield
With hydrogenchloride; D-sorbitol; choline chloride In water at 25℃; for 3h;60%
ethyl 2-methoxyacetate
3938-96-3

ethyl 2-methoxyacetate

2-amino-1-(4-methyoxyphenyl)propane
64-13-1

2-amino-1-(4-methyoxyphenyl)propane

A

(R)-N-[2-(4'-methoxyphenyl)-1-methylethyl]-2-methoxyacetamide
1351781-80-0

(R)-N-[2-(4'-methoxyphenyl)-1-methylethyl]-2-methoxyacetamide

B

(S)-2-(4-methoxy-phenyl)-1-methyl-ethylamine
58993-78-5

(S)-2-(4-methoxy-phenyl)-1-methyl-ethylamine

C

(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

Conditions
ConditionsYield
With Candida antartica lipase B; triethylamine In n-heptane at 50℃; for 25h; Inert atmosphere; Enzymatic reaction; optical yield given as %ee;A 49%
B 40%
C n/a
With Candida antartica lipase B; triethylamine In n-heptane at 35℃; for 1.5h; Inert atmosphere; Enzymatic reaction; optical yield given as %ee;A 38%
B n/a
C n/a
N-[(1R)-2-(4-methoxyphenyl)-1-methylethyl]-N-[(1R)-1-phenylethyl]amine hydrochloride

N-[(1R)-2-(4-methoxyphenyl)-1-methylethyl]-N-[(1R)-1-phenylethyl]amine hydrochloride

(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal In methanol; water
1-methoxy-4-((E)-2-nitroprop-1-enyl)benzene
37629-51-9

1-methoxy-4-((E)-2-nitroprop-1-enyl)benzene

A

(S)-2-(4-methoxy-phenyl)-1-methyl-ethylamine
58993-78-5

(S)-2-(4-methoxy-phenyl)-1-methyl-ethylamine

B

(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

Conditions
ConditionsYield
Stage #1: 1-methoxy-4-((E)-2-nitroprop-1-enyl)benzene With lithium aluminium tetrahydride In diethyl ether for 2h; Reduction; Heating;
Stage #2: With Candida antarctica lipase B; ethyl acetate; triethylamine at 30℃; for 4h; racemate resolution; Title compound not separated from byproducts;
(R)-N-[1-(o-methoxyphenyl)propan-2-yl]ethanamide
86073-42-9

(R)-N-[1-(o-methoxyphenyl)propan-2-yl]ethanamide

(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

Conditions
ConditionsYield
With potassium hydroxide Hydrolysis; Heating;
2-amino-1-(4-methyoxyphenyl)propane
64-13-1

2-amino-1-(4-methyoxyphenyl)propane

(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: Candida antarctica lipase B
2: 3M aq. KOH / Heating
View Scheme
Multi-step reaction with 2 steps
1: Candida antartica lipase B; triethylamine / 35 °C / Inert atmosphere; Enzymatic reaction
2: water; potassium hydroxide / Reflux
View Scheme
Multi-step reaction with 2 steps
1: Candida antartica lipase B; triethylamine / n-heptane / 25 h / 50 °C / Inert atmosphere; Enzymatic reaction
2: water; potassium hydroxide / Reflux
View Scheme
Multi-step reaction with 2 steps
1: triethylamine / tetrahydrofuran / 0 - 20 °C / Inert atmosphere
2: water; potassium hydroxide / Reflux
View Scheme
1-methoxy-4-((E)-2-nitroprop-1-enyl)benzene
37629-51-9

1-methoxy-4-((E)-2-nitroprop-1-enyl)benzene

(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 78 percent / LiAlH4 / diethyl ether / 2 h / Heating
2: Candida antarctica lipase B
3: 3M aq. KOH / Heating
View Scheme
4-methoxy-benzaldehyde
123-11-5

4-methoxy-benzaldehyde

(E/Z)-crotylstannane(1-)*Et4N(1+)

(E/Z)-crotylstannane(1-)*Et4N(1+)

(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 81 percent / ammonium acetate / 0.58 h / Heating
2: 78 percent / LiAlH4 / diethyl ether / 2 h / Heating
3: Candida antarctica lipase B
4: 3M aq. KOH / Heating
View Scheme
Multi-step reaction with 2 steps
1.1: 81 percent / ammonium acetate / 0.58 h / Heating
2.1: LiAlH4 / diethyl ether / 2 h / Heating
2.2: Candida antarctica lipase B; ethyl acetate; Et3N / 4 h / 30 °C
View Scheme
l-para-Methoxyamphetamine hydrochloride
50505-80-1

l-para-Methoxyamphetamine hydrochloride

(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

Conditions
ConditionsYield
With ammonia; water In dichloromethane Product distribution / selectivity;
4-methoxybenzyl methyl ketone
122-84-9

4-methoxybenzyl methyl ketone

A

(S)-2-(4-methoxy-phenyl)-1-methyl-ethylamine
58993-78-5

(S)-2-(4-methoxy-phenyl)-1-methyl-ethylamine

B

(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

Conditions
ConditionsYield
With glucose dehydrogenase; D-Alanine; D-glucose; ω-transaminase ATA-117; pyridoxal 5'-phosphate; nicotinamide adenine dinucleotide; lactate dehydrogenase In dimethyl sulfoxide at 30℃; for 24h; pH=7; aq. phosphate buffer; Enzymatic reaction; optical yield given as %ee; stereoselective reaction;
With Escherichia coli overexpressing ω-transaminase from round 11 variant from Arthrobacter sp.; pyridoxal 5'-phosphate; isopropylamine In dimethyl sulfoxide at 45℃; pH=11; aq. buffer; Enzymatic reaction; optical yield given as %ee;
With pyridoxal 5'-phosphate; isopropylamine In aq. phosphate buffer at 30℃; for 5h; pH=9; Reagent/catalyst; Time; Enzymatic reaction;A n/a
B n/a
butanone
78-93-3

butanone

(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

Conditions
ConditionsYield
With glucose dehydrogenase; D-Alanine; D-glucose; ω-transaminase ATA-117; pyridoxal 5'-phosphate; nicotinamide adenine dinucleotide; lactate dehydrogenase In dimethyl sulfoxide at 30℃; for 24h; pH=7; aq. phosphate buffer; Enzymatic reaction; optical yield given as %ee; stereoselective reaction;
N-[2-(4'-methoxyphenyl)-1-methylethyl]-2-methoxyacetamide
1352411-20-1

N-[2-(4'-methoxyphenyl)-1-methylethyl]-2-methoxyacetamide

A

(S)-2-(4-methoxy-phenyl)-1-methyl-ethylamine
58993-78-5

(S)-2-(4-methoxy-phenyl)-1-methyl-ethylamine

B

(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

Conditions
ConditionsYield
With water; potassium hydroxide Reflux; optical yield given as %ee;
4-(2-nitro-propenyl)-anisole
17354-63-1

4-(2-nitro-propenyl)-anisole

(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: lithium aluminium tetrahydride / diethyl ether / 3 h / Inert atmosphere; Reflux
2: Candida antartica lipase B; triethylamine / 35 °C / Inert atmosphere; Enzymatic reaction
3: water; potassium hydroxide / Reflux
View Scheme
Multi-step reaction with 2 steps
1: lithium aluminium tetrahydride / diethyl ether / 3 h / Inert atmosphere; Reflux
2: Candida antartica lipase B; triethylamine / 35 °C / Inert atmosphere; Enzymatic reaction
View Scheme
Multi-step reaction with 2 steps
1: lithium aluminium tetrahydride / diethyl ether / 3 h / Inert atmosphere; Reflux
2: Candida antartica lipase B; triethylamine / n-heptane / 25 h / 50 °C / Inert atmosphere; Enzymatic reaction
View Scheme
Multi-step reaction with 3 steps
1: lithium aluminium tetrahydride / diethyl ether / 3 h / Inert atmosphere; Reflux
2: Candida antartica lipase B; triethylamine / n-heptane / 25 h / 50 °C / Inert atmosphere; Enzymatic reaction
3: water; potassium hydroxide / Reflux
View Scheme
Multi-step reaction with 3 steps
1: lithium aluminium tetrahydride / diethyl ether / 3 h / Inert atmosphere; Reflux
2: triethylamine / tetrahydrofuran / 0 - 20 °C / Inert atmosphere
3: water; potassium hydroxide / Reflux
View Scheme
2-amino-1-(4-methyoxyphenyl)propane
64-13-1

2-amino-1-(4-methyoxyphenyl)propane

ethyl acetate
141-78-6

ethyl acetate

A

(S)-N-[2-(4'-methoxyphenyl)-1-methylethyl]-2-methoxyacetamide

(S)-N-[2-(4'-methoxyphenyl)-1-methylethyl]-2-methoxyacetamide

B

(R)-N-[2-(4'-methoxyphenyl)-1-methylethyl]-2-methoxyacetamide
1351781-80-0

(R)-N-[2-(4'-methoxyphenyl)-1-methylethyl]-2-methoxyacetamide

C

(S)-2-(4-methoxy-phenyl)-1-methyl-ethylamine
58993-78-5

(S)-2-(4-methoxy-phenyl)-1-methyl-ethylamine

D

(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

Conditions
ConditionsYield
With Candida antartica lipase B; triethylamine at 35℃; Inert atmosphere; Enzymatic reaction; optical yield given as %ee;
4-methoxy-benzaldehyde
123-11-5

4-methoxy-benzaldehyde

(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: ammonium acetate / Reflux
2: lithium aluminium tetrahydride / diethyl ether / 3 h / Inert atmosphere; Reflux
3: Candida antartica lipase B; triethylamine / 35 °C / Inert atmosphere; Enzymatic reaction
4: water; potassium hydroxide / Reflux
View Scheme
Multi-step reaction with 3 steps
1: ammonium acetate / Reflux
2: lithium aluminium tetrahydride / diethyl ether / 3 h / Inert atmosphere; Reflux
3: Candida antartica lipase B; triethylamine / 35 °C / Inert atmosphere; Enzymatic reaction
View Scheme
Multi-step reaction with 3 steps
1: ammonium acetate / Reflux
2: lithium aluminium tetrahydride / diethyl ether / 3 h / Inert atmosphere; Reflux
3: Candida antartica lipase B; triethylamine / n-heptane / 25 h / 50 °C / Inert atmosphere; Enzymatic reaction
View Scheme
Multi-step reaction with 4 steps
1: ammonium acetate / Reflux
2: lithium aluminium tetrahydride / diethyl ether / 3 h / Inert atmosphere; Reflux
3: triethylamine / tetrahydrofuran / 0 - 20 °C / Inert atmosphere
4: water; potassium hydroxide / Reflux
View Scheme
Multi-step reaction with 4 steps
1: ammonium acetate / Reflux
2: lithium aluminium tetrahydride / diethyl ether / 3 h / Inert atmosphere; Reflux
3: Candida antartica lipase B; triethylamine / n-heptane / 25 h / 50 °C / Inert atmosphere; Enzymatic reaction
4: water; potassium hydroxide / Reflux
View Scheme
[2-(4-methoxy-phenyl)-1-methyl-ethyl]-(1-phenyl-ethyl)-amine

[2-(4-methoxy-phenyl)-1-methyl-ethyl]-(1-phenyl-ethyl)-amine

(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: L-Tartaric acid / ethanol
2: palladium 10% on activated carbon; hydrogen / methanol / 24 h / 40 °C / 1.5 MPa
View Scheme
1-(4-methoxyphenyl)propan-2-ol
131029-01-1, 30314-64-8

1-(4-methoxyphenyl)propan-2-ol

A

4-methoxybenzyl methyl ketone
122-84-9

4-methoxybenzyl methyl ketone

B

(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

Conditions
ConditionsYield
With amine dehydrogenase ChiAmDH; secondary alcohol dehydrogenase from Thermoanaerobacter ethanolicus W110A/G198D mutant; nicotinamide adenine dinucleotide; ammonium chloride pH=9; Enzymatic reaction; enantioselective reaction;A n/a
B n/a
N-(1-(R)-phenylethyl)propan-1-(4-methoxyphenyl)-2-imine

N-(1-(R)-phenylethyl)propan-1-(4-methoxyphenyl)-2-imine

(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: trichlorosilane; (8S,9S)-9-picolinamide(9-desoxy)-epi-cinchonidine / dichloromethane / 36 h / -20 °C / Inert atmosphere
2: palladium 10% on activated carbon / 1 h / 50 °C / 37503.8 Torr
View Scheme
N-(2-methylpropane-2-sulfinamide)-propan-1-(4-(methoxy)phenyl)-1-imine

N-(2-methylpropane-2-sulfinamide)-propan-1-(4-(methoxy)phenyl)-1-imine

A

(S)-2-(4-methoxy-phenyl)-1-methyl-ethylamine
58993-78-5

(S)-2-(4-methoxy-phenyl)-1-methyl-ethylamine

B

(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

Conditions
ConditionsYield
With (8S,9S)-9-picolinamide(9-desoxy)-epi-cinchonidine; trichlorosilane In dichloromethane for 0.5h; Flow reactor; Overall yield = 70 %; enantioselective reaction;A n/a
B n/a
inden-1-one
83-33-0

inden-1-one

A

(S)-2-(4-methoxy-phenyl)-1-methyl-ethylamine
58993-78-5

(S)-2-(4-methoxy-phenyl)-1-methyl-ethylamine

B

(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: titanium(IV) isopropylate / toluene / 0.08 h / Inert atmosphere
1.2: 18 h / 110 °C
2.1: trichlorosilane; (8S,9S)-9-picolinamide(9-desoxy)-epi-cinchonidine / dichloromethane / 0.5 h / Flow reactor
View Scheme
(+)-(R)-N-(1-phenylethyl)-N-[1-(p-methoxyphenyl)-2-propyl]amine hydrochloride

(+)-(R)-N-(1-phenylethyl)-N-[1-(p-methoxyphenyl)-2-propyl]amine hydrochloride

(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: hydrogen / palladium 10% on activated carbon / methanol / 8 - 10 h / 50 °C
1.2: pH 1 - 2
2.1: ammonia; water / dichloromethane
View Scheme
Estragole
140-67-0

Estragole

(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium 2,2,2-trifluoroacetate; iron(III) chloride; palladium(II) trifluoroacetate / acetonitrile; water / 30 °C / Inert atmosphere; Darkness
2: pyridoxal 5'-phosphate; isopropylamine; amine transaminase TA-P2-B01 / aq. phosphate buffer / 24 h / 30 °C / pH 7.5 / Enzymatic reaction
View Scheme
Multi-step reaction with 2 steps
1: iron(III) chloride; palladium(II) trifluoroacetate / water / 24 h / 60 °C / Inert atmosphere
2: pyridoxal 5'-phosphate; isopropylamine; amine transaminase TA-P2-B01 / aq. phosphate buffer / 24 h / 30 °C / pH 7.5 / Enzymatic reaction
View Scheme
Estragole
140-67-0

Estragole

A

(S)-2-(4-methoxy-phenyl)-1-methyl-ethylamine
58993-78-5

(S)-2-(4-methoxy-phenyl)-1-methyl-ethylamine

B

(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium 2,2,2-trifluoroacetate; iron(III) chloride; palladium(II) trifluoroacetate / acetonitrile; water / 30 °C / Inert atmosphere; Darkness
2: pyridoxal 5'-phosphate; isopropylamine; amine transaminase ATA-415 / aq. phosphate buffer / 24 h / 30 °C / pH 7.5 / Enzymatic reaction
View Scheme
Multi-step reaction with 2 steps
1: iron(III) chloride; palladium(II) trifluoroacetate / water / 24 h / 60 °C / Inert atmosphere
2: pyridoxal 5'-phosphate; isopropylamine; amine transaminase ATA-415 / aq. phosphate buffer / 24 h / 30 °C / pH 7.5 / Enzymatic reaction
View Scheme
C13H19NO2S

C13H19NO2S

(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: D-sorbitol; choline chloride / 0.03 h / 25 °C
2: D-sorbitol; choline chloride; hydrogenchloride / water / 3 h / 25 °C
View Scheme
Multi-step reaction with 2 steps
1: D-sorbitol; choline chloride / 0.03 h / 25 °C
2: D-sorbitol; choline chloride; hydrogenchloride / water / 3 h / 25 °C
View Scheme
(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

chloroacetyl chloride
79-04-9

chloroacetyl chloride

R(-)-chloro-N-[2-(4-methoxyphenyl)-1-methylethyl]acetamide

R(-)-chloro-N-[2-(4-methoxyphenyl)-1-methylethyl]acetamide

Conditions
ConditionsYield
With triethylamine In chloroform at 0 - 5℃; for 22 - 26h;95%
(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

benzaldehyde
100-52-7

benzaldehyde

(R)-(-)-1-(4'-methoxyphenyl)-2-benzylaminopropane
67346-60-5

(R)-(-)-1-(4'-methoxyphenyl)-2-benzylaminopropane

Conditions
ConditionsYield
With platinum on carbon; hydrogen In toluene at 80℃; under 3800.26 Torr; for 14h; Autoclave;91%
(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

(R)-1-(4-methoxyphenyl)-2-benzenesulfonylaminopropane

(R)-1-(4-methoxyphenyl)-2-benzenesulfonylaminopropane

Conditions
ConditionsYield
With sodium hydrogencarbonate; benzenesulfonyl chloride In dichloromethane; water88.6%
With sodium hydrogencarbonate; benzenesulfonyl chloride In dichloromethane; water88.6%
(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

propargyl bromide
106-96-7

propargyl bromide

(R)-N-(1-(4-methoxyphenyl)propan-2-yl)prop-2-yn-1-amine
1430326-04-7

(R)-N-(1-(4-methoxyphenyl)propan-2-yl)prop-2-yn-1-amine

Conditions
ConditionsYield
With potassium carbonate In toluene; acetonitrile at 20℃; for 16h; Inert atmosphere;60.6%
(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

(2R,3R,4S,5R)-2-(6-amino-2-chloro-9H-purin-9-yl)-5-(2-ethyl-2H-tetrazol-5-yl)tetrahydrofuran-3,4-diol
210239-94-4

(2R,3R,4S,5R)-2-(6-amino-2-chloro-9H-purin-9-yl)-5-(2-ethyl-2H-tetrazol-5-yl)tetrahydrofuran-3,4-diol

2-[1-(R)-methyl-2-(4-methoxyphenyl)ethylamino]-5’-(2-ethyl-2H-tetrazol-5-yl)adenosine

2-[1-(R)-methyl-2-(4-methoxyphenyl)ethylamino]-5’-(2-ethyl-2H-tetrazol-5-yl)adenosine

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dimethyl sulfoxide at 145℃; for 23h; Inert atmosphere;30%
R-(+)-α-trifluoromethyl-α-methoxy-phenylacetic acid
20445-31-2

R-(+)-α-trifluoromethyl-α-methoxy-phenylacetic acid

(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

(R)-3,3,3-Trifluoro-2-methoxy-N-[(R)-2-(4-methoxy-phenyl)-1-methyl-ethyl]-2-phenyl-propionamide

(R)-3,3,3-Trifluoro-2-methoxy-N-[(R)-2-(4-methoxy-phenyl)-1-methyl-ethyl]-2-phenyl-propionamide

Conditions
ConditionsYield
(i) SOCl2, (ii) /BRN= 3030840/, Py, CHCl3; Multistep reaction;
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride
(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

(R)-1-(3-Chloro-phenyl)-2-[(R)-2-(4-methoxy-phenyl)-1-methyl-ethylamino]-ethanol
176589-72-3

(R)-1-(3-Chloro-phenyl)-2-[(R)-2-(4-methoxy-phenyl)-1-methyl-ethylamino]-ethanol

Conditions
ConditionsYield
With hydrogenchloride; N-Trimethylsilylacetamide 1.) 110 deg C, 2.) EtOAc, 0 deg C to room temp.; Yield given. Multistep reaction;
(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

4-Chloro-pyridine-3-sulfonic acid [(S)-2-[4-(2-fluoro-ethyl)-piperidin-1-yl]-1-(4-nitro-benzyl)-2-oxo-ethyl]-amide
221624-33-5

4-Chloro-pyridine-3-sulfonic acid [(S)-2-[4-(2-fluoro-ethyl)-piperidin-1-yl]-1-(4-nitro-benzyl)-2-oxo-ethyl]-amide

4-[(R)-2-(4-Methoxy-phenyl)-1-methyl-ethylamino]-pyridine-3-sulfonic acid [(S)-2-[4-(2-fluoro-ethyl)-piperidin-1-yl]-1-(4-nitro-benzyl)-2-oxo-ethyl]-amide

4-[(R)-2-(4-Methoxy-phenyl)-1-methyl-ethylamino]-pyridine-3-sulfonic acid [(S)-2-[4-(2-fluoro-ethyl)-piperidin-1-yl]-1-(4-nitro-benzyl)-2-oxo-ethyl]-amide

Conditions
ConditionsYield
In ethanol Heating;
N,O-bis-(trimethylsilyl)-acetamide
10416-59-8

N,O-bis-(trimethylsilyl)-acetamide

(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

(R)-1-(4-benzyloxy-3-nitrophenyl)oxirane
188730-94-1

(R)-1-(4-benzyloxy-3-nitrophenyl)oxirane

[(R)-2-(4-Benzyloxy-3-nitro-phenyl)-2-trimethylsilanyloxy-ethyl]-[(R)-2-(4-methoxy-phenyl)-1-methyl-ethyl]-amine

[(R)-2-(4-Benzyloxy-3-nitro-phenyl)-2-trimethylsilanyloxy-ethyl]-[(R)-2-(4-methoxy-phenyl)-1-methyl-ethyl]-amine

Conditions
ConditionsYield
In dimethyl sulfoxide at 80℃; for 87h; Addition;
(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

2-(3-bromo-5-isoxazolyl)oxirane
76596-56-0

2-(3-bromo-5-isoxazolyl)oxirane

A

1-(3-bromo-isoxazol-5-yl)-2-[2-(4-methoxy-phenyl)-1-methyl-ethylamino]-ethanol

1-(3-bromo-isoxazol-5-yl)-2-[2-(4-methoxy-phenyl)-1-methyl-ethylamino]-ethanol

B

1-(3-bromo-isoxazol-5-yl)-2-[2-(4-methoxy-phenyl)-1-methyl-ethylamino]-ethanol

1-(3-bromo-isoxazol-5-yl)-2-[2-(4-methoxy-phenyl)-1-methyl-ethylamino]-ethanol

Conditions
ConditionsYield
With calcium(II) trifluoromethanesulfonate In acetonitrile for 24h; Heating;
(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

(R,R)-formoterol
73573-87-2

(R,R)-formoterol

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: dimethylsulfoxide / 87 h / 80 °C
2: neutral Al2O3 (activity III)
3: 67 percent / Fe turnings; 1M aq. HCl / methanol / 0.75 h / Heating
4: 69 percent / pyridine / 6.5 h / 60 °C
5: H2 / 10 percentPd/C / ethanol / 20 °C
View Scheme
(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

(R)-1-(3-Amino-4-benzyloxy-phenyl)-2-[(R)-2-(4-methoxy-phenyl)-1-methyl-ethylamino]-ethanol
299964-43-5

(R)-1-(3-Amino-4-benzyloxy-phenyl)-2-[(R)-2-(4-methoxy-phenyl)-1-methyl-ethylamino]-ethanol

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: dimethylsulfoxide / 87 h / 80 °C
2: neutral Al2O3 (activity III)
3: 67 percent / Fe turnings; 1M aq. HCl / methanol / 0.75 h / Heating
View Scheme
(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

(R)-1-(4-Benzyloxy-3-nitro-phenyl)-2-[(R)-2-(4-methoxy-phenyl)-1-methyl-ethylamino]-ethanol
245759-61-9

(R)-1-(4-Benzyloxy-3-nitro-phenyl)-2-[(R)-2-(4-methoxy-phenyl)-1-methyl-ethylamino]-ethanol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: dimethylsulfoxide / 87 h / 80 °C
2: neutral Al2O3 (activity III)
View Scheme
(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

N-(2-Benzyloxy-5-{(R)-1-hydroxy-2-[(R)-2-(4-methoxy-phenyl)-1-methyl-ethylamino]-ethyl}-phenyl)-formamide
408497-91-6

N-(2-Benzyloxy-5-{(R)-1-hydroxy-2-[(R)-2-(4-methoxy-phenyl)-1-methyl-ethylamino]-ethyl}-phenyl)-formamide

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: dimethylsulfoxide / 87 h / 80 °C
2: neutral Al2O3 (activity III)
3: 67 percent / Fe turnings; 1M aq. HCl / methanol / 0.75 h / Heating
4: 69 percent / pyridine / 6.5 h / 60 °C
View Scheme
(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

(R)-5-(3-Chloro-phenyl)-3-[(R)-2-(4-hydroxy-phenyl)-1-methyl-ethyl]-oxazolidin-2-one
176495-23-1

(R)-5-(3-Chloro-phenyl)-3-[(R)-2-(4-hydroxy-phenyl)-1-methyl-ethyl]-oxazolidin-2-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 1.) AcNHTMS, 2.) aq. HCl / 1.) 110 deg C, 2.) EtOAc, 0 deg C to room temp.
2: 90 percent / Et3N / CHCl3 / Ambient temperature
3: 81 percent / BBr3 / CH2Cl2 / 0 °C
View Scheme
(R)-(-)-p-methoxyamphetamine
58993-79-6

(R)-(-)-p-methoxyamphetamine

(R)-5-(3-Chloro-phenyl)-3-[(R)-2-(4-methoxy-phenyl)-1-methyl-ethyl]-oxazolidin-2-one
176495-21-9

(R)-5-(3-Chloro-phenyl)-3-[(R)-2-(4-methoxy-phenyl)-1-methyl-ethyl]-oxazolidin-2-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 1.) AcNHTMS, 2.) aq. HCl / 1.) 110 deg C, 2.) EtOAc, 0 deg C to room temp.
2: 90 percent / Et3N / CHCl3 / Ambient temperature
View Scheme

58993-79-6Relevant academic research and scientific papers

Iterative Alanine Scanning Mutagenesis Confers Aromatic Ketone Specificity and Activity of L-Amine Dehydrogenases

Mu, Xiaoqing,Wu, Tao,Mao, Yong,Zhao, Yilei,Xu, Yan,Nie, Yao

, p. 5243 - 5253 (2021/11/16)

Direct reductive amination of prochiral ketones catalyzed by amine dehydrogenases is attractive in the synthesis of active pharmaceutical ingredients. Here, we report the protein engineering of L-Bacillus cereus amine dehydrogenase to allow reactivity on synthetically useful aromatic ketone substrates using an iterative, multiple-site alanine scanning mutagenesis approach. Mutagenesis libraries based on molecular docking, iterative alanine scanning, and double-proximity filter approach significantly expand the scope of active pharmaceutical ingredients relevant building blocks. The eventual quintuple mutant (A115G/T136A/L42A/V296A/V293A) showed reactivity toward aromatic ketones 12 a (5-phenyl-pentan-2-one) and 13 a (6-phenyl-hexan-2-one), which have not been reported to serve as targets of reductive amination by currently available amine dehydrogenases. Docking simulation and tunnel analysis provided valuable insights into the source of the acquired specificity and activity.

Development of an engineered thermostable amine dehydrogenase for the synthesis of structurally diverse chiral amines

Chen, Fei-Fei,Chen, Qi,Liu, Lei,Wang, Dong-Hao,Wang, Zhi-Long,Xu, Jian-He,Zhang, Zhi-Jun,Zheng, Gao-Wei

, p. 2353 - 2358 (2020/05/13)

Amine dehydrogenases (AmDHs) are emerging as a class of attractive biocatalysts for synthesizing chiral amines via asymmetric reductive amination of ketones with inexpensive ammonia as an amino donor. However, the AmDHs developed to date exhibit limited substrate scope. Here, using directed evolution, we engineered a GkAmDH based on a thermostable phenylalanine dehydrogenase from Geobacillus kaustophilus. The newly developed AmDH is able to catalyze reductive amination of a diverse set of ketones and functionalized hydroxy ketones with ammonia or primary amines with up to >99% conversion, thus accessing structurally diverse chiral primary and secondary amines and chiral vicinal amino alcohols, with excellent enantioselectivity (up to >99% ee) and releasing water as the sole by-product.

Addition of Highly Polarized Organometallic Compounds to N-tert-Butanesulfinyl Imines in Deep Eutectic Solvents under Air: Preparation of Chiral Amines of Pharmaceutical Interest

Capriati, Vito,Cicco, Luciana,García-álvarez, Joaquín,González-Sabín, Javier,Perna, Filippo M.,Ríos-Lombardía, Nicolás,Salomone, Antonio,Vitale, Paola

, (2020/07/04)

Highly polarized organometallic compounds of s-block elements are added smoothly to chiral N-tert-butanesulfinyl imines in the biodegradable d-sorbitol/choline chloride eutectic mixture, thereby granting access to enantioenriched primary amines after quantitatively removing the sulfinyl group. The practicality of the method is further highlighted by proceeding at ambient temperature and under air, with very short reaction times (2 min), enabling the preparation of diastereoisomeric sulfinamides in very good yields (74–98 %) and with a broad substrate scope, and the possibility of scaling up the process. The method is demonstrated in the asymmetric syntheses of both the chiral amine side-chain of (R,R)-Formoterol (96 % ee) and the pharmaceutically relevant (R)-Cinacalcet (98 % ee).

An Ammonium-Formate-Driven Trienzymatic Cascade for ω-Transaminase-Catalyzed (R)-Selective Amination

Chen, Fei-Fei,Liu, Lei,Wu, Jian-Ping,Xu, Jian-He,Zhang, Yu-Hui,Zhang, Zhi-Jun,Zheng, Gao-Wei

, p. 14987 - 14993 (2019/12/02)

(R)-Amination mediated by (R)-specific ω-transaminases generally requires costly d-alanine in excess to obtain the desired chiral amines in high yield. Herein, a one-pot, trienzymatic cascade comprising an (R)-specific ω-transaminase, an amine dehydrogenase, and a formate dehydrogenase was developed for the economical and eco-friendly synthesis of (R)-chiral amines. Using inexpensive ammonium formate as the sole sacrificial agent, the established cascade system enabled efficient ω-transaminase-mediated (R)-amination of various ketones, with high conversions and excellent ee (>99%); water and CO2 were the only waste products.

Stereoselective Synthesis of 1-Arylpropan-2-amines from Allylbenzenes through a Wacker-Tsuji Oxidation-Biotransamination Sequential Process

González-Martínez, Daniel,Gotor, Vicente,Gotor-Fernández, Vicente

, p. 2582 - 2593 (2019/05/15)

Herein, a sequential and selective chemoenzymatic approach is described involving the metal-catalysed Wacker-Tsuji oxidation of allylbenzenes followed by the amine transaminase-catalysed biotransamination of the resulting 1-arylpropan-2-ones. Thus, a series of nine optically active 1-arylpropan-2-amines were obtained with good to very high conversions (74–92%) and excellent selectivities (>99% enantiomeric excess) in aqueous medium. The Wacker-Tsuji reaction has been exhaustively optimised searching for compatible conditions with the biotransamination experiments, using palladium(II) complexes as catalysts and iron(III) salts as terminal oxidants in aqueous media. The compatibility of palladium/iron systems for the chemical oxidation with commercially available and made in house amine transaminases was analysed, finding ideal conditions for the development of a general and stereoselective cascade sequence. Depending on the selectivity displayed by selected amine transaminase, it was possible to produce both 1-arylpropan-2-amines enantiomers under mild reaction conditions, compounds that present therapeutic properties or can be employed as synthetic intermediates of chiral drugs from the amphetamine family. (Figure presented.).

Upgraded Bioelectrocatalytic N2 Fixation: From N2 to Chiral Amine Intermediates

Chen, Hui,Cai, Rong,Patel, Janki,Dong, Fangyuan,Chen, Hsiaonung,Minteer, Shelley D.

, p. 4963 - 4971 (2019/03/26)

Enantiomerically pure chiral amines are of increasing value in the preparation of bioactive compounds, pharmaceuticals, and agrochemicals. ω-Transaminase (ω-TA) is an ideal catalyst for asymmetric amination because of its excellent enantioselectivity and wide substrate scope. To shift the equilibrium of reactions catalyzed by ω-TA to the side of the amine product, an upgraded N2 fixation system based on bioelectrocatalysis was developed to realize the conversion from N2 to chiral amine intermediates. The produced NH3 was in situ reacted with l-alanine dehydrogenase to generate alanine with NADH as a coenzyme. ω-TA transferred the amino group from alanine to ketone substrates and finally produced the desired chiral amine intermediates. The cathode of the upgraded N2 fixation system supplied enough reducing power to synchronously realize the regeneration of reduced methyl viologen (MV?+) and NADH for the nitrogenase and l-alanine dehydrogenase. The coproduct, pyruvate, was consumed by l-alanine dehydrogenase to regenerate alanine and push the equilibrium to the side of amine. After 10 h of reaction, the concentration of 1-methyl-3-phenylpropylamine achieved 0.54 mM with the 27.6% highest faradaic efficiency and >99% enantiomeric excess (eep). Because of the wide substrate scope and excellent enantioselectivity of ω-TA, the upgraded N2 fixation system has great potential to produce a variety of chiral amine intermediates for pharmaceuticals and other applications.

Improved synthetic method of (R)-1-aryl-2-propylamine

-

, (2018/07/30)

The invention provides an improved synthetic method of (R)-1-aryl-2-propylamine. The improved synthetic method comprises the following steps of: adopting 1-arylacetone as a raw material, adding (R)-1-phenylethylamine, carrying out reductive amination reaction with hydrogen under a common action of a Lewis acid additive and a transitional metal hydrogenation catalyst; carrying out Pd/C catalytic hydrogenation on an obtained intermediate to remove phenethyl on nitrogen and thus obtaining (R)-1-aryl-2-propylamine. The improved synthetic method provided by the invention has the beneficial effectsthat the operation is simple, the adopted Lewis acid additive is low in cost and easy in obtaining, the yield and the enantioselectivity of a product are high, and the application value for industrialsynthesis of (R)-1-aryl-2-propylamine is very high.

Direct Reductive Amination of Carbonyl Compounds with H2 Using Heterogeneous Catalysts in Continuous Flow as an Alternative to N-Alkylation with Alkyl Halides

Laroche, Benjamin,Ishitani, Haruro,Kobayashi, Shū

supporting information, p. 4699 - 4704 (2018/12/04)

A general continuous-flow procedure for direct reductive amination of secondary and primary amines with aromatic and aliphatic aldehydes as well as ketones is reported. The use of hydrogen gas and commercially available Pt/C as a heterogeneous catalyst is a key. In addition to exhibiting an excellent functional group tolerance, this method allows the fast formation of C?N bonds without production of any hazardous chemical waste. Applications to the synthesis of key intermediates toward active pharmaceutical ingredients (Donepezil and Arformoterol/Tamsulosin) are also described. (Figure presented.).

Amine dehydrogenases: Efficient biocatalysts for the reductive amination of carbonyl compounds

Knaus, Tanja,B?hmer, Wesley,Mutti, Francesco G.

supporting information, p. 453 - 463 (2017/08/14)

Amines constitute the major targets for the production of a plethora of chemical compounds that have applications in the pharmaceutical, agrochemical and bulk chemical industries. However, the asymmetric synthesis of α-chiral amines with elevated catalytic efficiency and atom economy is still a very challenging synthetic problem. Here, we investigated the biocatalytic reductive amination of carbonyl compounds employing a rising class of enzymes for amine synthesis: amine dehydrogenases (AmDHs). The three AmDHs from this study-operating in tandem with a formate dehydrogenase from Candida boidinii (Cb-FDH) for the recycling of the nicotinamide coenzyme-performed the efficient amination of a range of diverse aromatic and aliphatic ketones and aldehydes with up to quantitative conversion and elevated turnover numbers (TONs). Moreover, the reductive amination of prochiral ketones proceeded with perfect stereoselectivity, always affording the (R)-configured amines with more than 99% enantiomeric excess. The most suitable amine dehydrogenase, the optimised catalyst loading and the required reaction time were determined for each substrate. The biocatalytic reductive amination with this dual-enzyme system (AmDH-Cb-FDH) possesses elevated atom efficiency as it utilizes the ammonium formate buffer as the source of both nitrogen and reducing equivalents. Inorganic carbonate is the sole by-product.

Vicinal Diamines as Smart Cosubstrates in the Transaminase-Catalyzed Asymmetric Amination of Ketones

Payer, Stefan E.,Schrittwieser, Joerg H.,Kroutil, Wolfgang

supporting information, p. 2553 - 2559 (2017/05/12)

Transaminases (TAs) have recently been established as catalysts for the asymmetric, reductive amination of prochiral ketones. Depending on the ketone substrate and the amine donor (the cosubstrate), equilibrium constants may limit high conversions; thus, methods to overcome this limitation are required. Removal of the co-product from the reaction equilibrium through spontaneous, intramolecular reactions has provided a successful solution to this problem; therefore, these amine donors have been named “smart cosubstrates”. Here, we present a comparison of various bifunctional amine donors including vicinal diamines as potential structural cosubstrate motifs. Upon TA-catalyzed deamination of 1,2-diamines, spontaneous dimerization of the resulting α-aminoketones and oxidation gave heteroaromatic pyrazines.